HCA Healthcare/$HCA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About HCA Healthcare

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2024, the firm owned and operated 190 hospitals, 124 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.

Ticker

$HCA
Sector

Primary listing

NYSE

Employees

271,000

HCA Healthcare Metrics

BasicAdvanced
$101B
18.10
$23.73
1.40
$2.82
0.67%

What the Analysts think about HCA Healthcare

Analyst ratings (Buy, Hold, Sell) for HCA Healthcare stock.

Bulls say / Bears say

HCA increased its full-year 2025 earnings outlook to $25.50–27.00 per share from $24.05–25.85, signaling strong demand for medical procedures. (Reuters)
HCA reported adjusted EPS of $6.84 in Q2 2025, topping analyst estimates of $6.25, highlighting strong pricing power and operational efficiency. (Reuters)
In Q1 2025, HCA's EPS reached $6.45, outpacing forecasts of $5.76, while same-facility admissions rose 2.6%, reflecting robust volume recovery. (Reuters)
Same-facility inpatient surgeries dropped 0.3% and outpatient surgeries slipped 0.6% in Q2 2025, raising concerns about future revenue growth potential. (Reuters)
As of June 30, 2025, HCA had total debt of $44.483 billion compared to cash of $939 million, leaving the company highly leveraged and vulnerable to higher interest rates. (SEC)
HCA reached a $1.53 million settlement with California and other states over unlawful nurse training repayment agreements, pointing to potential regulatory and compliance issues. (California DOJ)
Data summarised monthly by Lightyear AI. Last updated on 30 Sept 2025.

HCA Healthcare Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

HCA Healthcare Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $HCA

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs